1. Home /
  2. Options


Big Blue Looks Like a Big Dud

We have decent odds of a new 52-week low in IBM over the next few weeks.

For Boeing and Johnson & Johnson: Where There's Smoke, There's Fire

Both BA and JNJ appear to have made decisions in which the bottom line took precedent over what they stand for as a company.

Ride This CSX Trade North

The railroad stock is primed to break out above its 200-day moving average.

If Intuitive Surgical Is Going to Move, It Will Be Immediately Post-Earnings

As the robotics sector of medicine begins to mature, ISRG finds itself as one of the old guard.

Novice Trade: Bank of America

Warren Buffett may be buying more BAC shares. Here's how to play a move higher.

Electronic Arts Has Developed an Interesting Look

I like the long call now.

Park-Ohio Holdings: An Under-the-Radar Opportunity

The diversified manufacturing and supply chain management company holds big upside potential based on expectations of earnings ahead.

Back for a Square Meal

Sentiment may be too negative on Square stock now.

Novice Trade: Nike

Shoe giant seems poised to break $100 a share, and here's a great call play to make.

Here's the Direction I'd Take With JD.com

JD.com separates itself from other e-commerce competitors by controlling its inventory and logistics.

Novice Trade: Bed Bath & Beyond

I don't expect BBBY's recent post-earnings rally to last.

'Toy' Around With This Target Trade

Partnership with Toys R Us will improve Target's dominance in the category.

Options Trading? Here's My Approach

I prefer to focus on companies for which I have some familiarity. That's a personal rule.

At What Price Do You Own Canopy Growth?

Why I'm leaning toward a trade in the former cannabis darling.

Want Income on Your Cash? This Options Strategy Rewards the Patient Trader

Let's use Roku as an illustration of the benefits of cash-secured ratio puts spreads.

Novice Trade: Alibaba

BABA's China-driven declines have been buying opportunities.

Trade SmileDirect Into the Teeth of Its Decline

SDC is being valued at the same multiple as competitors with significantly slower growth.

Slack Just Works - Either on Its Own or Under a Larger Umbrella

Is there room for three names in the workplace communication sector?

Sign Up Now for This Bullish DocuSign Play

The focus now should be on the $65 level.

Disney Has What It Takes to Make a Run at $150

The streaming service is going to be a home run.

Apple: The Curiously Strong Stock

Apple might be setting up for a new all-time high, and this is a forgone conclusion if the market makes another leg higher.

I'm Willing to Take a Small Roll of the Dice With Chewy

The chart on Chewy is one ugly mutt, there's no denying it, but the price action turned this week.

Talk to Chuck With This Schwab Trade

These guys are going to make a lot of money by moving to this route.

Okta in October: Time to Act on Some Pummeled Cloud Stocks

October is a scary month, but the cloud sector had its comeuppance during September.

Intermediate Trade: TLT

Bonds are an interesting trade right now.

Cloudflare Operates in a Highly Coveted Space

It's tough to get overly aggressive, but if the company should fall, say another 25%, it might be too hard for growth investors to pass up.

2 Sagging Stocks That Could Make Good Covered Call Plays

Camping World and American Airlines have had tough years but looks like call option candidates as their prospects improve.

Uber Has Found a Bit of Life

Several factors could set us up for a bounce play in a grossly oversold name.

Novice Trade: Alibaba

BABA's rebound is far from over.

3 Biotech Plays That Would Work as Covered Calls

The SPDR S&P Biotech ETF, Alexion Pharmaceuticals and BioMarin Pharmaceuticals set up nicely for this options strategy.